Overview
Tobacco dependence, episodic, refers to recurrent episodes of nicotine addiction requiring intervention to reduce smoking frequency and ultimately achieve cessation. Effective management involves pharmacological and behavioral strategies tailored to individual patient needs 1.Diagnosis
Key Criteria: History of tobacco use, nicotine dependence symptoms (e.g., cravings, withdrawal), and unsuccessful attempts at quitting 1.
Recommended Tests: No specific diagnostic tests; clinical assessment and validated questionnaires (e.g., Fagerström Test for Nicotine Dependence) are commonly used 1.Management
First-Line Treatments:
- Varenicline: Recommended dose typically 1 mg twice daily 1.
- Nicotine Replacement Therapy (NRT): Various forms (patch, gum, inhaler) based on patient preference and dependence level 1.
- Bupropion: Standard dose often 150 mg twice daily 1.
Adjunctive Treatments:
- Combined Therapy: Combination of varenicline and NRT is more effective, especially in highly dependent smokers 1.
- Dose Optimization: Increasing doses of current medications may be considered if initial response is inadequate 1.Special Populations
Pregnancy: Specific pharmacological recommendations vary; expert opinion suggests prioritizing behavioral support over pharmacological interventions due to safety concerns 1.
Pediatrics: Limited evidence; behavioral interventions are prioritized, with pharmacological options requiring careful consideration and expert consultation 1.
Elderly: Similar to general population, but dose adjustments may be necessary due to comorbidities and polypharmacy 1.
Comorbidities: Management should consider potential drug interactions; varenicline and bupropion may be preferred over NRT in patients with certain psychiatric comorbidities 1.Key Recommendations
Use varenicline or combined nicotine therapy for superior efficacy in tobacco cessation (Evidence: Strong 1).
Consider combined pharmacological therapy (e.g., varenicline + NRT) in highly dependent smokers (Evidence: Strong 1).
Increase doses or optimize treatment strategies if initial response is inadequate (Evidence: Moderate 1).References
1 Rábade-Castedo C, de Granda-Orive JI, Riesco-Miranda JA, De Higes-Martínez E, Ramos-Pinedo Á, Cabrera-César E et al.. Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023. Archivos de bronconeumologia 2023. link